{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19368117", "DateCompleted": {"Year": "2009", "Month": "05", "Day": "05"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0258-851X", "JournalIssue": {"Volume": "23", "Issue": "1", "PubDate": {"Year": "2009", "Season": "Jan-Feb"}}, "Title": "In vivo (Athens, Greece)", "ISOAbbreviation": "In Vivo"}, "ArticleTitle": "Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products.", "Pagination": {"StartPage": "1", "EndPage": "6", "MedlinePgn": "1-6"}, "Abstract": {"AbstractText": ["Acquired immune deficiency syndrome (AIDS) caused by infection with the human immunodeficiency virus (HIV) represents a major health problem worldwide, especially in developing countries. Combinational anti-HIV therapy has largely improved patients' lives, but is not widely available in developing countries. Moreover, drug resistance is a main problem during HIV treatment. Therefore, there is a continuous need for new drugs effective against otherwise drug-resistant HIV strains. Chemical compounds from natural sources provide a large variety of potential anti-HIV compounds. The most promising natural products are discussed in this review."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Heidelberg, Institute of Pharmacy and Molecular Biotechnology, Heidelberg, Germany."}], "Identifier": [], "LastName": "Hupfeld", "ForeName": "Julia", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "In Vivo", "NlmUniqueID": "8806809", "ISSNLinking": "0258-851X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-HIV Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Acquired Immunodeficiency Syndrome"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-HIV Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Drug Resistance, Viral"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mutation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "NumberOfReferences": "41"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2009", "Month": "4", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "4", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "5", "Day": "6", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19368117"]}}], "PubmedBookArticle": []}